Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures

被引：9
|
作者：
Thoueille, Paul [1 ,2 ]
Cavassini, Matthias [2 ,3 ]
Guidi, Monia [1 ,2 ,4 ,5 ]
Buclin, Thierry [1 ,2 ]
Girardin, Francois R. [1 ,2 ]
Decosterd, Laurent A. [1 ,2 ]
Marzolini, Catia [1 ,6 ,7 ,8 ,9 ]
机构：
[1] Lausanne Univ Hosp, Dept Lab Med & Pathol, Serv & Lab Clin Pharmacol, Lausanne, Switzerland
[2] Univ Lausanne, Lausanne, Switzerland
[3] Lausanne Univ Hosp, Dept Med, Serv Infect Dis, Lausanne, Switzerland
[4] Lausanne Univ Hosp, Ctr Res & Innovat Clin Pharmaceut Sci, Lausanne, Switzerland
[5] Univ Lausanne, Univ Geneva, Inst Pharmaceut Sci Western Switzerland, Geneva, Switzerland
[6] Univ Basel, Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland
[7] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool, England
[8] Lausanne Univ Hosp, Dept Lab Med & Pathol, Serv & Lab Clin Pharmacol, Rue Bugnon 17, Lausanne, Switzerland
[9] Univ Lausanne, Rue Bugnon 17, Lausanne, Switzerland
来源：
OPEN FORUM INFECTIOUS DISEASES | 2024年 / 11卷 / 02期
基金：
瑞士国家科学基金会;
关键词：
cabotegravir; guidance; long-acting; rilpivirine; TDM; ADULTS;
D O I：
10.1093/ofid/ofae023
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The interpretation of long-acting cabotegravir and rilpivirine concentrations is complicated by the lack of consensus on the threshold to consider. Building on real-world therapeutic drug monitoring data and documented virologic failures, this article provides a reappraisal of the existing thresholds and guidance for the interpretation of cabotegravir and rilpivirine concentrations. There is no established threshold for the interpretation of long-acting cabotegravir/rilpivirine concentrations. Building on real-world TDM data and documented virologic failures, this article provides a reappraisal of the existing thresholds, and guidance for the interpretation of cabotegravir and rilpivirine concentrations.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] PrEP15-19 Choices: an implementation study protocol of HIV prevention with oral and long-acting injectable cabotegravir PrEP in real-world settings among sexual and gender minority adolescents in Brazil
    Dourado, Ines
    Dezanet, Lorenza
    Magno, Laio
    Westin, Mateus
    Soares, Fabiane
    Massa, Paula
    Zucchi, Eliana Miura
    Rossi, Thais Regis Aranha
    Caires, Priscilla
    Vasconcelos, Ricardo de Paula
    Couto, Marcia Thereza
    Tupinambas, Unai
    Greco, Dirceu
    Grangeiro, Alexandre D.
    BMJ OPEN, 2025, 15 (01):
  • [32] Long-Term Effectiveness and Safety of Proactive Therapeutic Drug Monitoring of Infliximab in Paediatric Inflammatory Bowel Disease: A Real-World Study
    Bautista, Susana Clemente
    Canton, Oscar Segarra
    Padulles-Zamora, Nuria
    Garcia, Sonia Garcia
    Beltran, Marina Alvarez
    Garcia, Maria Larrosa
    Poy, Maria Josep Cabanas
    Sanz-Martinez, Maria Teresa
    Vazquez, Ana
    Torner, Maria Queralt Gorgas
    Miarons, Marta
    PHARMACEUTICS, 2024, 16 (12)
  • [33] Tumour necrosis factor inhibitors in Ulcerative colitis: real-world data on Therapeutic drug monitoring and evaluation of current treatment targets (STRIDE II)
    Lundekvam, Jonas Andre
    Hoivik, Marte Lie
    Anisdahl, Karoline
    Smastuen, Milada Cvancarova
    Warren, David J.
    Bolstad, Nils
    Medhus, Asle Wilhelm
    ANNALS OF MEDICINE, 2025, 57 (01)
  • [34] Model Based Estimation of Posaconazole Tablet and Suspension Bioavailability in Hospitalized Children Using Real-World Therapeutic Drug Monitoring Data in Patients Receiving Intravenous and Oral Dosing
    Kane, Zoe
    Cheng, Iek
    McGarrity, Orlagh
    Chiesa, Robert
    Klein, Nigel
    Cortina-Borja, Mario
    Standing, Joseph F. F.
    Gastine, Silke
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (07)
  • [35] Long-acting injectable Cabotegravir (CAB-LA) pilot implementation at primary healthcare level in resource-limited settings: Early real-world evidence from the USAID DISCOVER-Health Project in Zambia
    Ndhlovu, A. P.
    Kawanga, L.
    Phiri, D.
    Nyumbu, M.
    Musonda, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27
  • [36] Comparison of the real-world safety of two different long-acting methylphenidate formulations (Medikinet® MR and Concerta®) - a Danish nationwide register-based cohort study
    Ornberg, Jakob
    Mayer, Anke
    Dangel, Oliver
    Ammer, Richard
    SCANDINAVIAN JOURNAL OF CHILD AND ADOLESCENT PSYCHIATRY AND PSYCHOLOGY, 2024, 12 (01): : 84 - 91
  • [37] USE OF SECOND-GENERATION LONG-ACTING INSULIN ANALOGS: REAL-WORLD DATA ON INSULIN DEGLUDEC AND INSULIN GLARGIN U 300 FROM THE GERMAN DPV REGISTRY
    Danne, T.
    Bramlage, P.
    Merger, S.
    Wagner, C.
    Laubner, K.
    Kress, S.
    Hermann, J.
    Holl, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A130 - A131
  • [38] Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
    Luis Gutiérrez‐Rojas
    Sergio Sánchez-Alonso
    Marta García Dorado
    Paola M. López Rengel
    CNS Drugs, 2022, 36 : 517 - 527
  • [39] Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
    Gutierrez-Rojas, Luis
    Sanchez-Alonso, Sergio
    Garcia Dorado, Marta
    Lopez Rengel, Paola M.
    CNS DRUGS, 2022, 36 (05) : 517 - 527
  • [40] Liver injury due to endothelin receptor antagonists: a real-world study based on post-marketing drug monitoring data
    Dong, Shichao
    Guo, Xiaofei
    Wang, Huayu
    Sun, Chuan
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2024, 18
12345